Iodipamide Meglumine

Also known as: Adipiodone, Meglumine Adipiodone

Drug #1933

Iodipamide meglumine is used to determine patency of cystic duct and common bile duct. The most important characteristic of contrast media is the iodine content. The relatively high atomic weight of iodine contributes sufficient radiodensity for radiographic contrast of the uterus and uterine tubes with surrounding tissues.

← Previous drug Next drug →

Primary Characteristics

Iodipamide Meglumine is also known as Adipiodone, Meglumine Adipiodone.

Molecular Weight: 1530.2 · Non-proprietary name: Iodipamide Meglumine.

Molecular structure of Iodipamide Meglumine

Pharmacokinetics

None recorded.

Indications

Iodipamide Meglumine is primarily indicated in conditions like Cholecystography, Hysterosalpingography.

Contraindications

Iodipamide Meglumine is contraindicated in conditions like Hepatic dysfunction, Pregnancy, Renal dysfunction, Hypersensitivity to any component of product.

Dosage

Iodipamide Meglumine's dosage details are as follows:

Dose	Single Dose	Frequency	Route	Instructions
Adult Dosage
20 ml	20 ml	—	IV	Intravenous, 20 mL of a solution containing the equivalent of 260 mg of iodine per mL administered slowly over a period of ten minutes, not to be repeated for twenty-four hours.
100 ml	100 ml	—	IV	Intravenous drip infusion, 100 mL of a solution containing the equivalent of 51 mg of iodine per mL, administered slowly over a period of thirty to forty-five minutes.
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Iodipamide Meglumine produces potentially life-threatening effects which include Hypersensitivity . Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Iodipamide Meglumine are Bradycardia, Hypotension, Anaphylactoid reactions, Cardiac arrest.

Iodipamide Meglumine is known to cause more or less tolerable side effects which are usually transient. These include Chills, Dizziness, Fever, Flushing, Nausea and vomiting, Rashes , Sweating .

Warnings / Precautions

Diagnostic procedures which involve the use of radiopaque diagnostic agents should be carried out under the direction of personnel with the prerequisite training and with a thorough knowledge of the particular procedure to be performed. The possibility of a reaction should always be considered. Patients at increased risk include those with a history of a previous reaction to a contrast medium, patients with a known sensitivity to iodine, and patients with a known clinical hypersensitivity: bronchial asthma, hay fever, and food allergies.

Interference in Pathology

Iodipamide Meglumine may interfere in the diagnosis of Urinanalysis , Elevations of SGPT and SGOT , Elevation in ALT or AST, Increased level of Blood urea nitrogen (BUN) concentrations, Increased in serum creatinin.

Available Brands

None recorded.

Storage Conditions

Iodipamide Meglumine should be stored Parentral.

Drug Classification

1.14.2 — Radiocontrast media